Medtronic Receives FDA Approval for Diabetes Management System

Shares

Medtronic, Inc. announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm® REAL-Time Revel™ System, an integrated diabetes management system which combines insulin pump therapy, continuous glucose monitoring (CGM) and diabetes therapy management software. The system incorporates new innovative CGM features including predictive alerts that can give early warning to people with diabetes so they can take action to prevent dangerous high or low glucose events.
This new system is another step towards the development of an Artificial Pancreas.

0 0 vote
Article Rating
Subscribe
Notify of
guest
1 Comment
newest
oldest most voted
Inline Feedbacks
View all comments
Bob Hawkinson
10 years ago

I love you guys at Medtronic…… No seriously…You are doing great work!

Copyright © 2009-2020 Diabetes Media Foundation, All Rights Reserved.
ASweetLife™ is a trademark of the Diabetes Media Foundation, All Rights Reserved.
DMCA Compliant
1
0
Would love your thoughts, please comment.x
()
x